In the field of pharmaceuticals, the term ‘polymorphism’ refers to the existence of a single substance in two or more crystalline forms. These different forms can vary widely in their efficacy, bioavailability and even toxicity. An EU-funded project is working to develop a method for directing polymorphism in pharmaceutical compounds, thus promising better drug treatments for patients everywhere.

Source: Research Information Centre
Directed polymorphism may lead to better treatments